Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematological disorders, cancer and rare immune diseases.
Fourth Quarter and Full Year 2022 Financial Results
Receive updates straight into your inbox
Rigel Pharmaceuticals, Inc.
611 Gateway Blvd
Suite 900
South San Francisco, CA 94080
Rigel Pharmaceuticals, Inc.
ir@rigel.com
EQ Shareowner Services
T: 800-401-1957